Cargando...
Neoadjuvant therapy for gastrointestinal stromal tumor
Molecular-targeting therapy using tyrosine kinase inhibitor imatinib mesylate is effective for metastasis/recurrent gastrointestinal stromal tumors (GISTs). Likewise, imatinib would be effective in the neoadjuvant therapy for high-risk GIST. Neoadjuvant therapy may have the potential to increase the...
Gardado en:
| Publicado en: | Transl Gastroenterol Hepatol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
AME Publishing Company
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5803029/ https://ncbi.nlm.nih.gov/pubmed/29441368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2018.01.01 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|